Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FPTase inhibitior series reported by Schering-Plough

Nov. 20, 1996

Fujisawa describes new agents for thrombocytopenia

Nov. 20, 1996

New farnesyl protein transferase series synthesized at Merck & Co.

Nov. 20, 1996

Cysteine protease inhibitors revealed by Takeda

Nov. 19, 1996

Hycamtin approved in Europe

Nov. 19, 1996

Antineoplastic PTP inhibitors disclosed by Department of Health & Human Services

Nov. 19, 1996

RCT reports novel circular oligonucleotides

Nov. 19, 1996

NO donors reported for cancer chemotherapy

Nov. 19, 1996

NIH awards grant for gene therapy approach to improving cancer treatment

Nov. 19, 1996

EGFR tyrosine kinase inhibitors described by Pfizer

Nov. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.